A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice.
Saved in:
| Title: | A controlled-release mitochondrial protonophore attenuates early- and late-stage atheroprogression in mice. |
|---|---|
| Authors: | Dos Santos BG; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Brisnovali NF; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Haney C; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Coven M; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Sebzevari HL; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Gaebel L; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Zhang X; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06510, USA.; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA., Sun J; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06510, USA.; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA.; Department of Pathology, Yale School of Medicine, New Haven, CT 06510, USA., Canfrán-Duque A; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06510, USA.; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA., Rotllan N; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06510, USA.; Integrative Cell Signaling and Neurobiology of Metabolism Program, Department of Comparative Medicine, Yale School of Medicine, New Haven, CT 06510, USA., Nasiri A; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA., Kahn M; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA., McAlpine CS; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Shulman GI; Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.; Department of Cellular and Molecular Physiology, Yale School of Medicine, New Haven, CT 06510, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA., Goedeke L; Department of Medicine (Cardiology), Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.; Department of Medicine (Endocrinology), Diabetes, Obesity and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. |
| Source: | Science translational medicine [Sci Transl Med] 2026 Jul 15; Vol. 18 (858), pp. eadv1815. Date of Electronic Publication: 2026 Jul 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1946-6242 |
|---|---|
| DOI: | 10.1126/scitranslmed.adv1815 |
